Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
about
Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cellsIdentification of functional microRNAs released through asymmetrical processing of HIV-1 TAR elementThe C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T CellsThe Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell ApoptosisRecruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cellsTwo dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expressionHIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interactionRegulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageEmergence of a complex relationship between HIV-1 and the microRNA pathway.Cell surface heparan sulfate and its roles in assisting viral infections.Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replicationThe presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral productionHIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.Molecular Understanding of HIV-1 Latency.The presence of the TAR RNA structure alters the programmed -1 ribosomal frameshift efficiency of the human immunodeficiency virus type 1 (HIV-1) by modifying the rate of translation initiation.Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat.Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat.Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury.Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer.DTL, the Drosophila homolog of PIMT/Tgs1 nuclear receptor coactivator-interacting protein/RNA methyltransferase, has an essential role in development.Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site.
P2860
Q21245111-1E0BB3EE-8E4C-44F5-A10A-AA11863AA55AQ22242847-54F3EBCE-DF58-4D4E-AC99-2BD61F0BFD3DQ22248066-98A2555E-7B64-4AD7-86AD-DDAC6D6BFF92Q22248069-D64C2832-763E-460D-AAF1-C8A5B4B57FF1Q24679559-A9DF157A-763C-4B2A-AAAC-511F01D71673Q28204738-9E03996C-A9DE-4C64-BEDA-A24895C03E90Q30010274-0A54D089-6D9F-4AFE-8746-0C0136E5EF6FQ30350982-E045BEED-8A5C-4829-9281-A25B57CF2FC1Q33346504-D6624C52-70B0-4A64-9525-38889EAF4C2BQ33532625-4BE7B181-D522-41BE-98EB-07C3DF19F304Q33633451-F8996C1D-52AD-4DAA-9030-61532BEAF7E8Q33864438-37C71E34-179B-48FD-8F3F-874B8D55D44AQ34025960-0DE50469-D1BE-4D50-ABD7-BC7727663E49Q34464575-87F954D6-7FDC-4843-8E08-2249F5844986Q36063046-4EDCCD93-7F2C-4614-8696-0542872E2547Q36685165-70597669-C3D4-4749-8A5A-573E6622AEA6Q37607912-C6AA34D2-C9E8-43F5-B2C6-5173DC3C3465Q39622803-421B86ED-F8C9-43DA-AE8E-04F0C7ECDADBQ40056035-9A495966-D388-4BD5-8EFF-326A6E3FBE43Q40142273-EE36E98C-19B0-4542-87F4-295A31F883B3Q40273841-F4929348-342A-4659-8206-7532764B4DD5Q40486626-93A82FD6-7533-4924-813E-84CA55F9707EQ40743714-452BE7AD-6E4B-4F12-A589-F4A3A88770CDQ40812571-8C5FB1CC-180E-41DA-BF28-25E04AEB4891Q40903523-66CCC76E-DD72-472C-A67D-7CF9D2C57EC2Q41926635-7303962C-D82D-4B0B-8AB0-A78BC2E61376Q42287214-4F262B74-3030-4EF8-9B92-A414AD85FE30Q42317502-EAE9311B-BD6A-41D8-A0ED-64C428D93EADQ42646699-18AF3DAC-7AB9-45D7-AD38-18AFBA3C93F0Q47149126-501C6DDF-0792-419C-9395-6CE7B1F427F5
P2860
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@ast
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@en
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@nl
type
label
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@ast
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@en
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@nl
prefLabel
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@ast
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@en
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@nl
P1476
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
@en
P2093
P304
P356
10.1016/S1054-3589(00)48007-5
P577
2000-01-01T00:00:00Z